Fig. 3.
Fig. 3. Sp17 is expressed on the surface of normal circulating lymphocytes. / (A) PBMCs from healthy donors were dual stained with antiserum to Sp17 and a monoclonal antibody specific for T lymphocytes (anti-CD3) or B lymphocytes (anti-CD19) and then analyzed by flow cytometry. Dot plots (upper panels) show the subpopulation of CD3+ and CD19+ cells, and histograms (lower panels) show the staining profile for Sp17 of those 2 subpopulations. (B) Sp17 is also present on polymorphonuclear leukocytes (PMNs) and monocytes. To distinguish PMN and monocyte populations, the light scatter pattern (forward versus side light scatter) was used. Data in panels A and B are representative of 2 to 4 independent experiments. (C) Amplification of Sp17 mRNA by RT-PCR confirms that normal PBMCs are producing the cell surface Sp17 that is detected by flow cytometry.

Sp17 is expressed on the surface of normal circulating lymphocytes.

(A) PBMCs from healthy donors were dual stained with antiserum to Sp17 and a monoclonal antibody specific for T lymphocytes (anti-CD3) or B lymphocytes (anti-CD19) and then analyzed by flow cytometry. Dot plots (upper panels) show the subpopulation of CD3+ and CD19+ cells, and histograms (lower panels) show the staining profile for Sp17 of those 2 subpopulations. (B) Sp17 is also present on polymorphonuclear leukocytes (PMNs) and monocytes. To distinguish PMN and monocyte populations, the light scatter pattern (forward versus side light scatter) was used. Data in panels A and B are representative of 2 to 4 independent experiments. (C) Amplification of Sp17 mRNA by RT-PCR confirms that normal PBMCs are producing the cell surface Sp17 that is detected by flow cytometry.

Close Modal

or Create an Account

Close Modal
Close Modal